Cambridge's Moderna Gets FDA Fast Track Approval For Potential Coronavirus Vaccine
Cambridge's Moderna Gets FDA Fast Track Approval For Potential Coronavirus Vaccine

Cambridge biotech company Moderna says it’s received a big boost from the FDA to fast track its development of a potential coronavirus vaccine.